Trintellix and Nuvaring drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Trintellix (vortioxetine hydrobromide) and Nuvaring (ethinyl estradiol; etonogestrel). Common drug interactions include pancreatitis among females.

The phase IV clinical study analyzes what interactions people have when they take Trintellix and Nuvaring. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Trintellix?

Trintellix has active ingredients of vortioxetine hydrobromide. It is often used in depression. eHealthMe is studying from 13,067 Trintellix users. Check the latest studies of Trintellix.

What is Nuvaring?

Nuvaring has active ingredients of ethinyl estradiol; etonogestrel. It is often used in birth control. eHealthMe is studying from 28,730 Nuvaring users. Check the latest studies of Nuvaring.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.



On Aug, 14, 2026

11 people who take Trintellix and Nuvaring together, and have interactions are studied.

Trintellix and Nuvaring drug interactions.

What are the common drug interactions of Trintellix and Nuvaring, by gender? *:

female:

  1. Pancreatitis (inflammation of pancreas)
  2. Appetite disorder (abnormal eating habits)
  3. Pelvic pain
  4. Vaginal haemorrhage (vaginal bleeding)
  5. Vaginal infection
  6. Influenza like illness
  7. Insomnia (sleeplessness)
  8. Libido decreased (loss of interest in sex)
  9. Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
  10. Menstrual disorder (disease of menstrual cycle)

male:

n/a

What are the common drug interactions of Trintellix and Nuvaring, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Libido decreased (loss of interest in sex)
  2. Ovarian cyst (fluid filled sac of the ovary)
  3. Pelvic pain

30-39:

  1. Pancreatitis (inflammation of pancreas)
  2. Appetite disorder (abnormal eating habits)
  3. Influenza like illness
  4. Insomnia (sleeplessness)
  5. Menorrhagia (an abnormally heavy bleeding and prolonged menstrual period at regular intervals)
  6. Menstrual disorder (disease of menstrual cycle)
  7. Vaginal haemorrhage (vaginal bleeding)

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 36.36%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 3 people, 27.27%
  3. Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 2 people, 18.18%
  4. Stress And Anxiety: 1 person, 9.09%
  5. Menstrual Disorder (disease of menstrual cycle): 1 person, 9.09%
  6. Insomnia (sleeplessness): 1 person, 9.09%
  7. Attention Deficit Hyperactivity Disorder (a chronic condition including attention difficulty, hyperactivity, and impulsiveness): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Trintellix and Nuvaring?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Trintellix and Nuvaring:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Trintellix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nuvaring:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Trintellix and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nuvaring and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on vortioxetine hydrobromide and ethinyl estradiol; etonogestrel (the active ingredients of Trintellix and Nuvaring, respectively), and Trintellix and Nuvaring (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: